TuHURA BIOSCIENCES, INC./NV Goodwill
TuHURA BIOSCIENCES, INC./NV (HURA) had Goodwill of $10.74 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-08-14
- 2026-06-30: Goodwill $10.74M.
- 2026-03-31: Goodwill $10.74M.
- 2025-12-31: Goodwill $10.74M.
- 2025-09-30: Goodwill $13.55M.
| Period end | Goodwill |
|---|---|
| 2026-06-30 | $10.74M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $10.74M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $10.74M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $13.55M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $13.55M 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |